ProCE Banner Activity


Expanding Options for Managing Migraine

Interactive Video Lecture

In recent years, the treatment landscape for migraine has expanded immensely—and now includes triptans, gepants, and CGRP antagonists, among others. With the expansion in medication options, choosing the optimal agent for your patient can be complex. In this video lecture, an expert breaks down the various available drug classes, their indications, and comorbidities and patient factors that may influence migraine treatment choice. Also discussed are signs and symptoms to be aware of in migraine diagnosis, the difference between acute and chronic migraine, and nonpharmaceutical strategies to complement pharmaceutical treatment.

Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: March 31, 2022

Expiration: March 30, 2023

No longer available for credit.



Maureen Moriarty

Maureen Moriarty, DNP, ANP-BC

Associate Professor
Malek School of Nursing Professions
Marymount University
Arlington, Virginia
Moriarty Associates: A Comprehensive Headache Center
Westminster, Maryland

Susan Tiso

Susan Tiso, DNP, FNP-BC

Consultant; Retired Clinical Professor
Sue & Bill Gross School of Nursing
Family Nurse Practitioner
Department of Family Medicine
University of California, Irvine
Irvine, California


This program is cosupported by educational grants from Alcon Vision, LLC; Biohaven Pharmaceuticals; Genentech, a member of the Roche Group; Gilead Sciences, Inc.; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

This activity is supported by an educational grant from Biohaven Pharmaceuticals.

Provided by

ProCE Banner


Biohaven Pharmaceuticals, Inc

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Assess patients with symptoms suggestive of migraine using appropriate screening tools and criteria

  • Implement strategies for migraine treatment and prevention based on current evidence-based guidelines

  • Determine suitable medication options for both episodic and chronic migraine prevention and treatment


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Herman: fees for non-CME/CE services: Novo Nordisk.

Dr Moriarty: consulting fees/fees for non-CME/CE services: Allergan/Abbvie, Amgen, Biohaven, Lilly; contracted research: Teva.

Dr Tiso has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Herman as noted above.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: March 31, 2022
Expiration date: March 30, 2023


Interactive video lecture


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Lawrence Herman, DMSc, MPA, PA-C, University of Lynchburg, Lynchburg, Virginia

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.